Evanston Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,733
| Closed | -$240K | – | 73 |
|
|
2018
Q3 | $240K | Buy |
+5,733
| New | +$240K | 0.05% | 62 |
|
|
2017
Q1 | – | Sell |
-216,088
| Closed | -$6.66M | – | 67 |
|
|
2016
Q4 | $6.66M | Buy |
216,088
+13,276
| +7% | +$409K | 2.05% | 24 |
|
|
2016
Q3 | $6.52M | Sell |
202,812
-3,877
| -2% | -$125K | 2.04% | 20 |
|
|
2016
Q2 | $6.91M | Buy |
206,689
+202
| +0.1% | +$6.75K | 2.25% | 9 |
|
|
2016
Q1 | $5.81M | Buy |
206,487
+5,408
| +3% | +$152K | 1.91% | 31 |
|
|
2015
Q4 | $6.16M | Buy |
201,079
+2,881
| +1% | +$88.2K | 2.15% | 24 |
|
|
2015
Q3 | $5.91M | Buy |
198,198
+9,686
| +5% | +$289K | 1.96% | 24 |
|
|
2015
Q2 | $6M | Sell |
188,512
-2,423
| -1% | -$77.1K | 1.97% | 17 |
|
|
2015
Q1 | $6.3M | Sell |
190,935
-12,004
| -6% | -$396K | 2.06% | 11 |
|
|
2014
Q4 | $6M | Buy |
202,939
+4
| +0% | +$118 | 2.12% | 17 |
|
|
2014
Q3 | $5.69M | Buy |
202,935
+10,416
| +5% | +$292K | 1.93% | 20 |
|
|
2014
Q2 | $5.42M | Buy |
192,519
+10,025
| +5% | +$282K | 1.88% | 23 |
|
|
2014
Q1 | $5.56M | Sell |
182,494
-1,890
| -1% | -$57.6K | 1.99% | 10 |
|
|
2013
Q4 | $5.36M | Buy |
184,384
+4,714
| +3% | +$137K | 2.02% | 22 |
|
|
2013
Q3 | $4.9M | Buy |
179,670
+7,405
| +4% | +$202K | 1.97% | 21 |
|
|
2013
Q2 | $4.58M | Buy |
+172,265
| New | +$4.58M | 2.03% | 22 |
|